NB‐UVB phototherapy response of different body regions in non‐segmental vitiligo

Journal of the European Academy of Dermatology and VenereologyVolume 37, Issue 6 p. e782-e785 LETTER TO THE EDITOR NB-UVB phototherapy response of different body regions in non-segmental vitiligo This article relates to: Deciphering differential response to NB-UVB: The hair matters Rhea Ahuja, Somesh Gupta, Journal of the European Academy of Dermatology and Venereology First Published online: November 16, 2023 Vidhya S. Narayan, Corresponding Author Vidhya S. Narayan [email protected] orcid.org/0000-0003-4328-1132 Department of Dermatology, Netherlands Institute for Pigment Disorders, Amsterdam Infection and Immunity Institute, Amsterdam University Medical Centers, Location University of Amsterdam, Amsterdam, The Netherlands Correspondence Vidhya S. Narayan, Department of Dermatology, Netherlands Institute for Pigment Disorders, Amsterdam University Medical Centers, Location University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands. Email: [email protected]Search for more papers by this authorElnaz Alagha, Elnaz Alagha Department of Dermatology, Netherlands Institute for Pigment Disorders, Amsterdam Infection and Immunity Institute, Amsterdam University Medical Centers, Location University of Amsterdam, Amsterdam, The NetherlandsSearch for more papers by this authorWouter Ouwerkerk, Wouter Ouwerkerk Department of Dermatology, Netherlands Institute for Pigment Disorders, Amsterdam Infection and Immunity Institute, Amsterdam University Medical Centers, Location University of Amsterdam, Amsterdam, The Netherlands National Heart Centre Singapore, Hospital Drive, Singapore City, SingaporeSearch for more papers by this authorSanne E. Uitentuis, Sanne E. Uitentuis orcid.org/0000-0002-6031-2116 Department of Dermatology, Netherlands Institute for Pigment Disorders, Amsterdam Infection and Immunity Institute, Amsterdam University Medical Centers, Location University of Amsterdam, Amsterdam, The NetherlandsSearch for more papers by this authorJanny E. Lommerts, Janny E. Lommerts Department of Dermatology, Netherlands Institute for Pigment Disorders, Amsterdam Infection and Immunity Institute, Amsterdam University Medical Centers, Location University of Amsterdam, Amsterdam, The NetherlandsSearch for more papers by this authorSamia Esmat, Samia Esmat Department of Dermatology, Faculty of Medicine Cairo University, Cairo, EgyptSearch for more papers by this authorRania M. Mogawer, Rania M. Mogawer Department of Dermatology, Faculty of Medicine Cairo University, Cairo, EgyptSearch for more papers by this authorNanis Ragab, Nanis Ragab Department of Dermatology, Faculty of Medicine Cairo University, Cairo, EgyptSearch for more papers by this authorSai Yee Chuah, Sai Yee Chuah orcid.org/0000-0003-1321-4377 Department of Dermatology, National Skin Centre, Singapore City, SingaporeSearch for more papers by this authorSteven Thng, Steven Thng Department of Dermatology, National Skin Centre, Singapore City, SingaporeSearch for more papers by this authorAlbert Wolkerstorfer, Albert Wolkerstorfer Department of Dermatology, Netherlands Institute for Pigment Disorders, Amsterdam Infection and Immunity Institute, Amsterdam University Medical Centers, Location University of Amsterdam, Amsterdam, The NetherlandsSearch for more papers by this authorRosalie M. Luiten, Rosalie M. Luiten Department of Dermatology, Netherlands Institute for Pigment Disorders, Amsterdam Infection and Immunity Institute, Amsterdam University Medical Centers, Location University of Amsterdam, Amsterdam, The NetherlandsSearch for more papers by this authorMarcel W. Bekkenk, Marcel W. Bekkenk Department of Dermatology, Netherlands Institute for Pigment Disorders, Amsterdam Infection and Immunity Institute, Amsterdam University Medical Centers, Location University of Amsterdam, Amsterdam, The NetherlandsSearch for more papers by this author Vidhya S. Narayan, Corresponding Author Vidhya S. Narayan [email protected] orcid.org/0000-0003-4328-1132 Department of Dermatology, Netherlands Institute for Pigment Disorders, Amsterdam Infection and Immunity Institute, Amsterdam University Medical Centers, Location University of Amsterdam, Amsterdam, The Netherlands Correspondence Vidhya S. Narayan, Department of Dermatology, Netherlands Institute for Pigment Disorders, Amsterdam University Medical Centers, Location University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands. Email: [email protected]Search for more papers by this authorElnaz Alagha, Elnaz Alagha Department of Dermatology, Netherlands Institute for Pigment Disorders, Amsterdam Infection and Immunity Institute, Amsterdam University Medical Centers, Location University of Amsterdam, Amsterdam, The NetherlandsSearch for more papers by this authorWouter Ouwerkerk, Wouter Ouwerkerk Department of Dermatology, Netherlands Institute for Pigment Disorders, Amsterdam Infection and Immunity Institute, Amsterdam University Medical Centers, Location University of Amsterdam, Amsterdam, The Netherlands National Heart Centre Singapore, Hospital Drive, Singapore City, SingaporeSearch for more papers by this authorSanne E. Uitentuis, Sanne E. Uitentuis orcid.org/0000-0002-6031-2116 Department of Dermatology, Netherlands Institute for Pigment Disorders, Amsterdam Infection and Immunity Institute, Amsterdam University Medical Centers, Location University of Amsterdam, Amsterdam, The NetherlandsSearch for more papers by this authorJanny E. Lommerts, Janny E. Lommerts Department of Dermatology, Netherlands Institute for Pigment Disorders, Amsterdam Infection and Immunity Institute, Amsterdam University Medical Centers, Location University of Amsterdam, Amsterdam, The NetherlandsSearch for more papers by this authorSamia Esmat, Samia Esmat Department of Dermatology, Faculty of Medicine Cairo University, Cairo, EgyptSearch for more papers by this authorRania M. Mogawer, Rania M. Mogawer Department of Dermatology, Faculty of Medicine Cairo University, Cairo, EgyptSearch for more papers by this authorNanis Ragab, Nanis Ragab Department of Dermatology, Faculty of Medicine Cairo University, Cairo, EgyptSearch for more papers by this authorSai Yee Chuah, Sai Yee Chuah orcid.org/0000-0003-1321-4377 Department of Dermatology, National Skin Centre, Singapore City, SingaporeSearch for more papers by this authorSteven Thng, Steven Thng Department of Dermatology, National Skin Centre, Singapore City, SingaporeSearch for more papers by this authorAlbert Wolkerstorfer, Albert Wolkerstorfer Department of Dermatology, Netherlands Institute for Pigment Disorders, Amsterdam Infection and Immunity Institute, Amsterdam University Medical Centers, Location University of Amsterdam, Amsterdam, The NetherlandsSearch for more papers by this authorRosalie M. Luiten, Rosalie M. Luiten Department of Dermatology, Netherlands Institute for Pigment Disorders, Amsterdam Infection and Immunity Institute, Amsterdam University Medical Centers, Location University of Amsterdam, Amsterdam, The NetherlandsSearch for more papers by this authorMarcel W. Bekkenk, Marcel W. Bekkenk Department of Dermatology, Netherlands Institute for Pigment Disorders, Amsterdam Infection and Immunity Institute, Amsterdam University Medical Centers, Location University of Amsterdam, Amsterdam, The NetherlandsSearch for more papers by this author First published: 03 February 2023 https://doi.org/10.1111/jdv.18946Citations: 1Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat REFERENCES 1Nordal EJ, Guleng GE, Rönnevig JR. Treatment of vitiligo with narrowband-UVB (TL01) combined with tacrolimus ointment (0.1%) vs. placebo ointment, a randomized right/left double-blind comparative study. J Eur Acad Dermatol Venereol. 2011; 25(12): 1440–3. https://doi.org/10.1111/J.1468-3083.2011.04002.X 10.1111/J.1468?3083.2011.04002.X CASPubMedWeb of Science®Google Scholar 2Esfandiarpour I, Ekhlasi A, Farajzadeh S, Shamsadini S. The efficacy of pimecrolimus 1% cream plus narrow-band ultraviolet B in the treatment of vitiligo: a double-blind, placebo-controlled clinical trial. J Dermatolog Treat. 2009; 20(1): 14–8. https://doi.org/10.1080/09546630802155057 10.1080/09546630802155057 CASPubMedWeb of Science®Google Scholar 3Thomas KS, Batchelor JM, Akram P, Chalmers JR, Haines RH, Meakin GD, et al. Randomized controlled trial of topical corticosteroid and home-based narrowband ultraviolet B for active and limited vitiligo: results of the HI-light vitiligo trial. Br J Dermatol. 2021; 184(5): 828–39. https://doi.org/10.1111/BJD.19592 10.1111/BJD.19592 CASPubMedWeb of Science®Google Scholar 4Frez Ma Lorna F, Ong Bernice Elaine T, Lim-Ong Melody dS, Leveriza Rosanna M.S. Comparison between narrow-band UVB with topical corticosteroid and narrow-band UVB with placebo in the treatment of vitiligo: a randomized controlled trial. J Philippine Dermatol Soc. 2005; 14: 17–25. Google Scholar 5Zubair R, Hamzavi IH. Phototherapy for vitiligo. Dermatol Clin. 2020; 38(1): 55–62. https://doi.org/10.1016/j.det.2019.08.005 10.1016/j.det.2019.08.005 CASPubMedWeb of Science®Google Scholar 6Kanwar AJ, Mahajan R, Parsad D. Low-dose oral mini-pulse dexamethasone therapy in progressive unstable vitiligo. J Cutan Med Surg. 2013; 17(4): 259–68. https://doi.org/10.2310/7750.2013.12053 10.2310/7750.2013.12053 CASPubMedWeb of Science®Google Scholar 7Eleftheriadou V, Atkar R, Batchelor J, McDonald B, Novakovic L, Patel JV, et al. British Association of Dermatologists guidelines for the management of people with vitiligo 2021. Br J Dermatol. 2022; 186(1): 18–29. https://doi.org/10.1111/BJD.20596 10.1111/BJD.20596 CASPubMedWeb of Science®Google Scholar 8Esmat SM, El-Mofty M, Rasheed H, Mostafa WZ, Anbar TS, Abdallah M, et al. Efficacy of narrow band UVB with or without OMP in stabilization of vitiligo activity in skin photo-types (III-V): a double-blind, randomized, placebo-controlled, prospective, multicenter study. Photodermatol Photoimmunol Photomed. 2022; 38(3): 277–87. https://doi.org/10.1111/PHPP.12749 10.1111/PHPP.12749 CASPubMedWeb of Science®Google Scholar 9van Geel N, Lommerts J, Bekkenk M, Wolkerstorfer A, Prinsen CAC, Eleftheriadou V, et al. Development and validation of the vitiligo extent score (VES): an international collaborative initiative. J Invest Dermatol. 2016; 136(5): 978–84. https://doi.org/10.1016/j.jid.2015.12.040 10.1016/j.jid.2015.12.040 PubMedWeb of Science®Google Scholar 10Uitentuis SE, Wolkerstorfer A, Bae JM, Esmat S, Mogawer RM, Ragab N, et al. Assessing the minimal important change in the vitiligo extent score and the self-assessment vitiligo extent score. J Am Acad Dermatol. 2021; 85(5): 1363–4. https://doi.org/10.1016/J.JAAD.2020.10.061 10.1016/J.JAAD.2020.10.061 PubMedWeb of Science®Google Scholar Citing Literature Volume37, Issue6June 2023Pages e782-e785 ReferencesRelatedInformation